Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test

BACKGROUND/AIMS: Potassium-competitive acid blockers are expected to be the next generation of drugs for the treatment of diseases caused by gastric acid. In 2015, vonoprazan fumarate, a novel potassium-competitive acid blocker, was approved by the Japanese health insurance system. Since its approva...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaoka, Tatsuhiro, Kameyama, Hisako, Yamane, Tsuyoshi, Yamamoto, Yuta, Takeuchi, Hiroya, Suzuki, Hidekazu, Kitagawa, Yuko, Kanai, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175552/
https://www.ncbi.nlm.nih.gov/pubmed/30347936
http://dx.doi.org/10.5056/jnm18036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175552/
https://www.ncbi.nlm.nih.gov/pubmed/30347936
http://dx.doi.org/10.5056/jnm18036

Ejemplares similares